Health Canada authorizes Moderna's COVID-19 vaccine in children (6-11 Years)
The announcement follows recent authorization of the Company's mRNA COVID-19 vaccine in Australia and the European Union for children aged 6-11 years
The announcement follows recent authorization of the Company's mRNA COVID-19 vaccine in Australia and the European Union for children aged 6-11 years
CEPI will expand its partnership with icddr,b in Bangladesh, providing near to the additional US $ 1 million in funding to advance understanding of the Nipah virus
MTBVAC is a global public-private project that will be a milestone in the field of vaccinology
A growing portfolio of chemicals is part of a larger quality management system that sets new standards in bioprocessing
The open-label, multicenter, randomized Phase 1 trial is designed to evaluate the safety and immunogenicity of experimental HIV trimer mRNA vaccines
The study looked at 1,364 children in Arizona, Florida, Texas, and Utah who submitted weekly nasal swabs and surveys from July 2021 through February 2022, regardless of whether they had symptoms
Intranasal immunization lowers the viral load below the limit of detection in lungs of hamsters
This innovative biomanufacturing technology will help to deliver cost-effective viral production that is unmatched in the industry
If approved, PreHevbri will be the only approved 3-antigen hepatitis B vaccine for adults in the E.U.
Medicago and GSK collaborated on Covifenz, an adjuvanted plant-based vaccine
Subscribe To Our Newsletter & Stay Updated